Top 5 Building Product Stocks To Own Right Now

Top 5 Building Product Stocks To Own Right Now: Opko Health Inc(OPK)

OPKO Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies primarily in the United States, Chile, and Mexico. It provides a range of solutions, including molecular diagnostics tests, proprietary pharmaceuticals, and vaccines to diagnose, treat, and prevent neurological disorders, infectious diseases, oncology, and ophthalmologic diseases. The company offers molecular diagnostic platform technology for the rapid identification of molecules or immunobiomarkers; Alzheimer?s test for Alzheimer?s diagnostic; and protein-based influenza vaccines to provide multi-season and multi-strain protection against various influenza virus strains, such as seasonal influenza strains, as well as global influenza pandemic strains which include swine flu, and avian flu. It also offers Oligonucleotide Therapeutics for the treatment of various illnesses, including cancer, heart disease, metabolic disorders, and genetic anomalies; and oligosaccharide for asthma and chronic obstructive pulmonary diseases. In addition, the company provides Rolapitant, a potent and antagonist; neurokinin-1, which has completed Phase II clinical trials for prevention of chemotherapy induced nausea and vomiting, and post-operative induced nausea and vomiting; and SCH 900978 that has completed Phase II clinical trials for chronic cough. Further, it offers bevasiranib, a drug candidate for the treatment of Wet AMD; and develops Aquashunt, a shunt to be used in the treatment of glaucoma. Additionally, the company involves in the development, commercialization, and sale of ophthalmic diagnostic and imaging systems, and instrumentation products. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Advisors' Opinion:

• [By GuruFocus]

  SVP & CFO Nimish S Bhatt bought 364 shares of CLMS stock on 11/20/2013 at the av! erage price of 10.47. Nimish S Bhatt owns at least 90,543 shares after this. The price of the stock has increased by 14.52% since.

  Opko Health, Inc. (OPK): CEO & Chairman, 10% Owner Phillip Md Et Al Frost Bought 62,100 Shares

  CEO & Chairman, 10% Owner of Opko Health, Inc. (OPK) Phillip Md Et Al Frost bought 62,100 shares during the past week at an average price of $8.57. Opko Health, Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics, Inc. Opko Health, Inc. has a market cap of $3.5 billion; its shares were traded at around $8.57 with and P/S ratio of 30.30.

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/top-5-building-product-stocks-to-own-right-now.html